Did not become law. It stopped in the House of Representatives's Health Committee on October 12, 2021. The 2021–2022 session has ended.
2021–2022 Regular Session
House Bill 1959
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
24 co-sponsors
Jennifer O'Mara, MaryLouise Isaacson, TINA M. DAVIS, Michael H. Schlossberg, TIMOTHY F. HENNESSEY, Carrie Lewis DelRosso, Nancy Guenst, F. Todd Polinchock, Matthew D. Dowling, Joe Hamm, Benjamin V. Sanchez, Christina D. Sappey, Brian Sims, Timothy J. O'Neal, Melissa L. Shusterman, KAREN BOBACK, Napoleon J. Nelson, Aaron Bernstine, Eric R. Nelson, Jeanne McNeill, Mary Jo Daley, Christopher B. Quinn, Greg Rothman, P. MICHAEL STURLA
Its course
October 12 to October 12, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesOct 12 to Oct 12 · stopped0 days
HealthOct 12 to Oct 12 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.